Patents
Patents for C07C 243 - Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes (2,826)
01/2007
01/09/2007CA2348288C Organic electrochromic materials for optical attenuation in the near infrared region
01/03/2007EP1334661B1 Ectoparasitic insect pest controllers for animals and their usage
01/03/2007CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
01/03/2007CN1293045C N-substituted aryloxy-oxalyl-N,N'-dihydrazide compounds and preparing process and application thereof
12/2006
12/20/2006CN1882332A Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/14/2006US20060281765 Such as 2-(4,6-dimethoxypyrimidine-2-ylcarbonyl)acetanilide; for use as intermediate in production of agricultural chemicals and medicines; (pyrimidine-2-yl)-2-propanonee compound reacted with hydrazine compound in the presence of an acid to produce indole compound, oxidizing, reducing, deacetylation
12/13/2006CN1878466A Biphenyl derivative or salt thereof, pest control agent containing the same as active ingredient
12/06/2006CN1288146C Process for production of substituted aniline compound
11/2006
11/23/2006US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006US20060264506 Meldonium salts, method of their preparation and pharmaceutical composition on their basis
11/22/2006CN1285605C Antitumour indolo pyrrolo carbazole derivatives
11/16/2006WO2006120125A1 Diacylglycerol acyltransferase inhibitors
11/16/2006CA2607121A1 Diacylglycerol acyltransferase inhibitors
11/15/2006EP1721890A1 Process for the allylation of n-acylhydrazones
11/15/2006CN1863763A Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and vap-1 mediated adhesion useful for treatment of diseases
11/08/2006EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/07/2006CA2284775C Preparation of low-dust stabilisers
11/02/2006WO2005108349A3 Process for preparing atazanavir bisulfate and novel forms
11/02/2006EP1717350A1 Antirust composition
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006CN1854123A Hydroxynaphthalenedicarboxylic acid hydrazide dimer and derivatives thereof as well as process for preparing them
10/2006
10/31/2006US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/26/2006DE4029119B4 Verfahren zur Herstellung von Monomethylhydrazin in wäßriger Lösung A process for preparing monomethyl in aqueous solution
10/24/2006US7125910 Compounds and compositions for delivering active agents
10/24/2006US7125871 Excitatory amino acid receptor modulators
10/19/2006US20060235244 Hydroxynaphthalenedicarboxylic acid hydrazide dimer and derivatives thereof as well as process for preparing them
10/18/2006EP1712546A1 Hydroxynaphthalenedicarboxylic acid hydrazide and derivatives thereof as well as process for preparing them
10/18/2006EP1712545A1 Hydroxynaphthalenedicarboxylic acid hydrazide dimer and derivatives thereof as well as process for preparing them
10/18/2006CN1847218A Hydroxynaphthalenedicarboxylic acid hydrazide and derivatives thereof as well as process for preparing them
10/12/2006WO2006105850A1 Acyl hydrazides as kinase inhibitors, in particular for sgk
10/12/2006CA2603475A1 Acyl hydrazides as kinase inhibitors, in particular for sgk
10/05/2006DE102005015255A1 New acylhydrazide compounds are signal transduction kinase inhibitor, useful for treating and/or preventing diseases, e.g. diabetes, adiposity, metabolic syndrome, cancer and tumor cells
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006CA2234518C Process for preparing substituted oxadiazolones
09/2006
09/27/2006CN1837169A Compound capable of inhibiting zinc ion metalloproteinases
09/21/2006US20060211860 Compounds for the treatment of Alzheimer's disease
09/14/2006WO2006096572A1 Ethambutol based nitric oxide donors
09/06/2006EP1698618A1 Benzamide derivative
09/06/2006EP1697348A1 Hiv protease inhibiting compounds
09/06/2006CN1829683A Mildronate salt and its preparation method, and pharmaceutical composition based on mildronate
09/05/2006US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration
08/2006
08/30/2006EP1180095B1 4-cyano-3-hydroxy butanoyl hydrazines, derivatives and process for the preparation thereof
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/24/2006WO2005112670A8 Molecularly imprinted polymers selective for nitrosamines and methods of using the same
08/23/2006EP1692110A1 Diacylhydrazine derivatives
08/10/2006WO2006082010A1 Inhibitors of diacylglycerol acyltransferase (dgat)
08/10/2006CA2596639A1 Inhibitors of diacylglycerol acyltransferase (dgat)
08/09/2006EP1687260A1 Nitroso derivatives of diphenylamine
08/08/2006US7087786 phenylpyrazole compounds or 5-amino-1-aryl-3-cyanopyrazole; high yield and high purity; eliminates the diazotization step and hence avoids hazards known to occur for such reactions
08/03/2006WO2006032893A3 Trityl derivatives for enhancing mass spectrometry
08/03/2006US20060173058 Kcnq channel modulating compounds and their pharmaceutical use
08/03/2006US20060172990 Antibacterial agents
08/02/2006CN1810770A Prepn process of acyldhydrazino adipate with free hydrazine content lower than 10ppm
07/2006
07/27/2006US20060167316 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/27/2006US20060166859 Compounds and compositions for delivering active agents
07/26/2006EP1681924A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
07/26/2006CN1807223A Dynamic molecule base electron device based on hydrazine derived biological molecular material
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2006US7081473 Glucose dependent-insulinotropic polypeptide, or gastric inhibitory polypeptide (GIP) inhibitors; p-methylidene hydrizide phenols
07/25/2006CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof
07/19/2006CN1805924A Method of forming a carbon-heteroatom bond
07/12/2006CN1800151A 1-naphthylhydrazine preparation method
07/11/2006US7074959 Applying dicarbonyl-compound solution to an object contaminated with a hydrazine group compound, wherein said hydrazine group compound is converted to a stable organic compound as a result
07/06/2006WO2006041797A3 Acyclic hydrazides as cannabinoid receptor modulators
07/06/2006WO2005108347A3 Substituted enaminones, their derivatives and uses thereof
07/05/2006EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/04/2006US7071214 Compounds and compositions for delivering active agents
06/2006
06/28/2006EP1673082A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
06/14/2006EP1667960A1 Meldonium salts, method of their preparation and pharmaceutical composition on their basis
06/08/2006WO2006058730A1 Hydrazide compounds for combating animal pests
06/08/2006US20060122428 Hydroxynaphthoic acid hydrazide compound and method for preparing the same
06/08/2006US20060122408 Photogenerated reagents
06/07/2006EP1663954A2 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases
06/01/2006WO2005034940A8 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
05/2006
05/30/2006US7053245 N-acylamino benzyl ether derivatives
05/25/2006US20060111590 Polymer-immobilized formamides, catalyst containing the same and allylation process
05/25/2006US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/23/2006US7049343 Nitrogen compounds such as 3-(N'-(2,6-dinitro-4-trifluoro methylphenyl)-N-(3-methoxyphenylhydrazino)propionic acid, used as glycine transport antagonists for prophylaxis of psychological disorders
05/17/2006CN1772730A Hydroxynaphthoic acid hydrazide compounds and method for preparing the same
05/17/2006CN1772729A Polymerisable fluorescent functional monomer and its prepn and use
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/16/2006US7045512 Controlling fungi in plants, seeds
05/11/2006WO2005123646A3 Fluoroorganic compounds and anti-fouling treatments
05/10/2006EP1655282A1 Hydroxynaphthoic acid hydrazide compounds and method for preparing the same
05/10/2006EP1654219A2 Hydrazide derivatives as prostaglandin receptors modulators
04/2006
04/26/2006CN1764374A Use of aromatic hydroxy compounds as safeners
04/25/2006US7034182 Compounds to treat Alzheimer's disease
04/20/2006CA2582588A1 Acyclic hydrazides as cannabinoid receptor modulators
04/12/2006CN1758925A Methods of radiofluorination of biologically active vectors
04/04/2006CA2258764C Inhibitors of oleamide hydrolase
03/2006
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006US20060069264 Aza hydroxylated ethyl amine compounds
03/29/2006CN1247572C Method of producing nitroguanidine-and nitroenamine derivatives
03/29/2006CN1247523C Substituted 1 and 2 naphthol mannich bases
03/28/2006US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders
03/28/2006US7019003 Bactericides
03/22/2006CN1749239A Method for synthesizing hydrogenated azo compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 29